Deep Brain Stimulation in Parkinsons Disease Market Size, Share, Trends, Growth Outlook

Deep Brain Stimulation in Parkinsons Disease Market is estimated to increase at a growth rate of 10.3% CAGR over the forecast period from 2024 to 2030.

The Deep Brain Stimulation in Parkinsons Disease Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Single Channel, Dual Channel), By End-User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers).

An Introduction to Deep Brain Stimulation in Parkinsons Disease Market in 2024

The Deep Brain Stimulation in Parkinson's Disease market in 2024 serves the demand for advanced neuromodulation therapies and medical devices aimed at managing motor symptoms and improving quality of life in patients with Parkinson's disease (PD) who are refractory to conventional pharmacological treatments. Deep brain stimulation (DBS) involves the implantation of electrodes in specific brain regions such as the subthalamic nucleus or globus pallidus interna, connected to an implanted pulse generator (IPG) via subcutaneous leads, delivering electrical impulses to modulate abnormal neuronal activity and alleviate motor symptoms such as tremors, rigidity, and bradykinesia. Market dynamics are driven by factors such as the increasing prevalence of Parkinson's disease, advancements in neurostimulation technology and surgical techniques, and the demand for alternative and adjunctive treatment options for patients with advanced PD. Collaboration between medical device manufacturers, neurologists, and neurosurgeons drives innovation and market expansion in deep brain stimulation, offering new hope and improved quality of life for patients living with this progressive and debilitating neurological disorder.

Deep Brain Stimulation in Parkinson's Disease Market Trend: Advancements in Deep Brain Stimulation (DBS) Technology

A prominent trend in the Deep Brain Stimulation (DBS) in Parkinson's Disease market is the continual advancements in DBS technology. Innovations such as next-generation electrodes, improved targeting techniques, and closed-loop systems are enhancing the efficacy, precision, and safety of DBS procedures. These technological advancements are enabling neurosurgeons to better tailor DBS therapy to individual patient needs, optimize stimulation parameters, and minimize adverse effects, thereby improving overall treatment outcomes for Parkinson's disease patients.

Deep Brain Stimulation in Parkinson's Disease Market Driver: Increasing Prevalence of Parkinson's Disease

The primary driver for the Deep Brain Stimulation (DBS) in Parkinson's Disease market is the increasing prevalence of Parkinson's disease globally. With aging populations and lifestyle factors contributing to the rise in neurodegenerative disorders, the demand for effective treatments like DBS is on the rise. DBS offers significant symptomatic relief for Parkinson's disease patients, especially those experiencing motor fluctuations and medication-resistant symptoms, driving its adoption as a preferred therapeutic option. The growing patient pool presents opportunities for market growth as healthcare providers seek to address the unmet needs of Parkinson's disease patients through DBS interventions.

Deep Brain Stimulation in Parkinson's Disease Market Opportunity: Expansion of Indications and Applications

An opportunity in the Deep Brain Stimulation (DBS) in Parkinson's Disease market lies in the expansion of indications and applications beyond Parkinson's disease. While DBS is well-established as a treatment for Parkinson's disease, there is growing interest in exploring its efficacy for other neurological and psychiatric conditions, such as essential tremor, dystonia, epilepsy, obsessive-compulsive disorder (OCD), and major depressive disorder (MDD). By expanding the scope of indications and applications, manufacturers and healthcare providers can tap into new patient populations, broaden their market reach, and drive revenue growth in the evolving field of neuromodulation therapy.

Deep Brain Stimulation in Parkinsons Disease Market Segmentation

By Product
Single Channel
Dual Channel
By End-user
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Deep Brain Stimulation in Parkinsons Disease Market Companies

Abbott Laboratories
Aleva Neurotherapeutics SA
Beijing Pins Medical Co. Ltd
Boston Scientific Corp
Functional Neuromodulation Ltd
General Electric Co.
Medtronic PLC
MicroTransponder Inc
Neuronetics Inc
NeuroPace Inc
NeuroSigma Inc
Nexstim Oy
Renishaw PLC
Siemens AG
St. Jude Medical nc.
Synapse Biomedical Inc

 

 

Reasons to Buy the Deep Brain Stimulation in Parkinsons Disease Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Deep Brain Stimulation in Parkinsons Disease Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Deep Brain Stimulation in Parkinsons Disease Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Deep Brain Stimulation in Parkinsons Disease Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Deep Brain Stimulation in Parkinsons Disease Market Size Outlook, $ Million, 2021 to 2030
3.2 Deep Brain Stimulation in Parkinsons Disease Market Outlook by Type, $ Million, 2021 to 2030
3.3 Deep Brain Stimulation in Parkinsons Disease Market Outlook by Product, $ Million, 2021 to 2030
3.4 Deep Brain Stimulation in Parkinsons Disease Market Outlook by Application, $ Million, 2021 to 2030
3.5 Deep Brain Stimulation in Parkinsons Disease Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Deep Brain Stimulation in Parkinsons Disease Market Industry
4.2 Key Market Trends in Deep Brain Stimulation in Parkinsons Disease Market Industry
4.3 Potential Opportunities in Deep Brain Stimulation in Parkinsons Disease Market Industry
4.4 Key Challenges in Deep Brain Stimulation in Parkinsons Disease Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Deep Brain Stimulation in Parkinsons Disease Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Deep Brain Stimulation in Parkinsons Disease Market Outlook By Segments
7.1 Deep Brain Stimulation in Parkinsons Disease Market Outlook by Segments
By Product
Single Channel
Dual Channel
By End-user
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers

8 North America Deep Brain Stimulation in Parkinsons Disease Market Analysis And Outlook To 2030
8.1 Introduction to North America Deep Brain Stimulation in Parkinsons Disease Markets in 2024
8.2 North America Deep Brain Stimulation in Parkinsons Disease Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Deep Brain Stimulation in Parkinsons Disease Market size Outlook by Segments, 2021-2030
By Product
Single Channel
Dual Channel
By End-user
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers

9 Europe Deep Brain Stimulation in Parkinsons Disease Market Analysis And Outlook To 2030
9.1 Introduction to Europe Deep Brain Stimulation in Parkinsons Disease Markets in 2024
9.2 Europe Deep Brain Stimulation in Parkinsons Disease Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Deep Brain Stimulation in Parkinsons Disease Market Size Outlook By Segments, 2021-2030
By Product
Single Channel
Dual Channel
By End-user
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers

10 Asia Pacific Deep Brain Stimulation in Parkinsons Disease Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Deep Brain Stimulation in Parkinsons Disease Markets in 2024
10.2 Asia Pacific Deep Brain Stimulation in Parkinsons Disease Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Deep Brain Stimulation in Parkinsons Disease Market size Outlook by Segments, 2021-2030
By Product
Single Channel
Dual Channel
By End-user
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers

11 South America Deep Brain Stimulation in Parkinsons Disease Market Analysis And Outlook To 2030
11.1 Introduction to South America Deep Brain Stimulation in Parkinsons Disease Markets in 2024
11.2 South America Deep Brain Stimulation in Parkinsons Disease Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Deep Brain Stimulation in Parkinsons Disease Market size Outlook by Segments, 2021-2030
By Product
Single Channel
Dual Channel
By End-user
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers

12 Middle East And Africa Deep Brain Stimulation in Parkinsons Disease Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Deep Brain Stimulation in Parkinsons Disease Markets in 2024
12.2 Middle East and Africa Deep Brain Stimulation in Parkinsons Disease Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Deep Brain Stimulation in Parkinsons Disease Market size Outlook by Segments, 2021-2030
By Product
Single Channel
Dual Channel
By End-user
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Aleva Neurotherapeutics SA
Beijing Pins Medical Co. Ltd
Boston Scientific Corp
Functional Neuromodulation Ltd
General Electric Co.
Medtronic PLC
MicroTransponder Inc
Neuronetics Inc
NeuroPace Inc
NeuroSigma Inc
Nexstim Oy
Renishaw PLC
Siemens AG
St. Jude Medical nc.
Synapse Biomedical Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Single Channel
Dual Channel
By End-user
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers